Sequenom, Inc

被引:17
作者
Cullinan, Amy [1 ]
Cantor, Charles [1 ]
机构
[1] Sequenom Inc, San Diego, CA 92121 USA
关键词
CNV; comparative sequence analysis; epigenetics; gene expression; genotyping; MALDlTOF mass spectrometry; mechylation; prenatal diagnostics; SNP;
D O I
10.2217/14622416.9.9.1211
中图分类号
R9 [药学];
学科分类号
1007 [药学];
摘要
Sequenom is an established genomic analysis company with two principal divisions: genetic analysis systems and reagents, and noninvasive prenatal diagnostics. As an industry innovator in DNA detection technology, Sequenom's benchtop MassARRAY (R) Compact system allows a direct mass measurement of nucleic acids, providing unparalleled precision and quantitation. The MassARRAY system is a multi-application MALDI-TOF MS platform for genotyping, methylation and quantitative gene expression analysis. Sequenom continues to refine these core applications and has developed several new applications for copy number variation analysis and comparative sequence analysis for bacteria and viruses. On the diagnostics front, Sequenom is developing a comprehensive portfolio of prenatal test methods by combining the versatility of the MassARRAY system with the company's SEQureDx (TM) technology, which enables the detection of circulating cell-free fetal nucleic acids in a maternal blood sample.
引用
收藏
页码:1211 / 1215
页数:5
相关论文
empty
未找到相关数据